These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 26661169)

  • 1. A cross-laboratory preclinical study on the effectiveness of interleukin-1 receptor antagonist in stroke.
    Maysami S; Wong R; Pradillo JM; Denes A; Dhungana H; Malm T; Koistinaho J; Orset C; Rahman M; Rubio M; Schwaninger M; Vivien D; Bath PM; Rothwell NJ; Allan SM
    J Cereb Blood Flow Metab; 2016 Mar; 36(3):596-605. PubMed ID: 26661169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed administration of interleukin-1 receptor antagonist reduces ischemic brain damage and inflammation in comorbid rats.
    Pradillo JM; Denes A; Greenhalgh AD; Boutin H; Drake C; McColl BW; Barton E; Proctor SD; Russell JC; Rothwell NJ; Allan SM
    J Cereb Blood Flow Metab; 2012 Sep; 32(9):1810-9. PubMed ID: 22781338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reparative effects of interleukin-1 receptor antagonist in young and aged/co-morbid rodents after cerebral ischemia.
    Pradillo JM; Murray KN; Coutts GA; Moraga A; Oroz-Gonjar F; Boutin H; Moro MA; Lizasoain I; Rothwell NJ; Allan SM
    Brain Behav Immun; 2017 Mar; 61():117-126. PubMed ID: 27856349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review and stratified meta-analysis of the efficacy of interleukin-1 receptor antagonist in animal models of stroke.
    Banwell V; Sena ES; Macleod MR
    J Stroke Cerebrovasc Dis; 2009; 18(4):269-76. PubMed ID: 19560680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-1 receptor antagonist in animal models of stroke: a fair summing up?
    Parry-Jones A; Boutin H; Denes A; McColl B; Hopkins S; Allan S; Tyrrell P
    J Stroke Cerebrovasc Dis; 2010; 19(6):512-3. PubMed ID: 20621515
    [No Abstract]   [Full Text] [Related]  

  • 6. Systematic Review and Meta-Analysis of the Efficacy of Interleukin-1 Receptor Antagonist in Animal Models of Stroke: an Update.
    McCann SK; Cramond F; Macleod MR; Sena ES
    Transl Stroke Res; 2016 Oct; 7(5):395-406. PubMed ID: 27526101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of neuroprotective effects of biphalin, an opioid receptor agonist, in a model of focal brain ischemia.
    Yang L; Shah K; Wang H; Karamyan VT; Abbruscato TJ
    J Pharmacol Exp Ther; 2011 Nov; 339(2):499-508. PubMed ID: 21856861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SCIL-STROKE (Subcutaneous Interleukin-1 Receptor Antagonist in Ischemic Stroke): A Randomized Controlled Phase 2 Trial.
    Smith CJ; Hulme S; Vail A; Heal C; Parry-Jones AR; Scarth S; Hopkins K; Hoadley M; Allan SM; Rothwell NJ; Hopkins SJ; Tyrrell PJ
    Stroke; 2018 May; 49(5):1210-1216. PubMed ID: 29567761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting CD36-mediated inflammation reduces acute brain injury in transient, but not permanent, ischemic stroke.
    Kim EH; Tolhurst AT; Szeto HH; Cho SH
    CNS Neurosci Ther; 2015 Apr; 21(4):385-91. PubMed ID: 25216018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dextromethorphan provides neuroprotection via anti-inflammatory and anti-excitotoxicity effects in the cortex following traumatic brain injury.
    Pu B; Xue Y; Wang Q; Hua C; Li X
    Mol Med Rep; 2015 Sep; 12(3):3704-3710. PubMed ID: 26004757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombolysis and neuroprotection in cerebral ischemia.
    Gutiérrez M; Díez Tejedor E; Alonso de Leciñana M; Fuentes B; Carceller F; Roda JM
    Cerebrovasc Dis; 2006; 21 Suppl 2():118-26. PubMed ID: 16651822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human interleukin-1 receptor antagonist in severe traumatic brain injury: a phase II randomized control trial.
    Helmy A; Guilfoyle MR; Carpenter KL; Pickard JD; Menon DK; Hutchinson PJ
    J Cereb Blood Flow Metab; 2014 May; 34(5):845-51. PubMed ID: 24569690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HAMI 3379, a CysLT2R antagonist, dose- and time-dependently attenuates brain injury and inhibits microglial inflammation after focal cerebral ischemia in rats.
    Shi QJ; Wang H; Liu ZX; Fang SH; Song XM; Lu YB; Zhang WP; Sa XY; Ying HZ; Wei EQ
    Neuroscience; 2015 Apr; 291():53-69. PubMed ID: 25681271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell therapy centered on IL-1Ra is neuroprotective in experimental stroke.
    Clausen BH; Lambertsen KL; Dagnæs-Hansen F; Babcock AA; von Linstow CU; Meldgaard M; Kristensen BW; Deierborg T; Finsen B
    Acta Neuropathol; 2016 May; 131(5):775-91. PubMed ID: 26860727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translating Animal Models of Ischemic Stroke to the Human Condition.
    Matur AV; Candelario-Jalil E; Paul S; Karamyan VT; Lee JD; Pennypacker K; Fraser JF
    Transl Stroke Res; 2023 Dec; 14(6):842-853. PubMed ID: 36125734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 1 alpha administration is neuroprotective and neuro-restorative following experimental ischemic stroke.
    Salmeron KE; Maniskas ME; Edwards DN; Wong R; Rajkovic I; Trout A; Rahman AA; Hamilton S; Fraser JF; Pinteaux E; Bix GJ
    J Neuroinflammation; 2019 Nov; 16(1):222. PubMed ID: 31727174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic inflammatory challenges compromise survival after experimental stroke via augmenting brain inflammation, blood- brain barrier damage and brain oedema independently of infarct size.
    Dénes A; Ferenczi S; Kovács KJ
    J Neuroinflammation; 2011 Nov; 8():164. PubMed ID: 22114895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vivo exploration of cerebral ischemia: use of neuroprotective agents in animal studies].
    Lestage P; Lockhart B; Roger A
    Therapie; 2002; 57(6):554-63. PubMed ID: 12666263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current therapies in ischemic stroke. Part B. Future candidates in stroke therapy and experimental studies.
    Broussalis E; Trinka E; Killer M; Harrer A; McCoy M; Kraus J
    Drug Discov Today; 2012 Jul; 17(13-14):671-84. PubMed ID: 22405898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel indication of platonin, a therapeutic immunomodulating medicine, on neuroprotection against ischemic stroke in mice.
    Sheu JR; Chen ZC; Jayakumar T; Chou DS; Yen TL; Lee HN; Pan SH; Hsia CH; Yang CH; Hsieh CY
    Sci Rep; 2017 Feb; 7():42277. PubMed ID: 28165057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.